Synergy of antiseizure and anxiolytic action of rapamycin and histamine H₃ inverse agonist pitolisant on the PTZ-kindled seizures

dc.contributor.author	Poshyvak, O. B.	en
dc.contributor.author	Pinyazhko, O. R.	en
dc.contributor.author	Pervak, M.	en
dc.contributor.author	Yehorenko, O. S.	en
dc.contributor.author	Prybolovets, K.	en
dc.contributor.author	Godlevsky, L. S.	en
dc.date.accessioned	2024-06-17T12:47:27Z
dc.date.available	2024-06-17T12:47:27Z
dc.date.issued	2023
dc.identifier.citation	Synergy of antiseizure and anxiolytic action of rapamycin and histamine H₃ inverse agonist pitolisant on the PTZ-kindled seizures / O.B. Poshyvak. Journal of the Neurological Sciences. 2023. Vol. 455. Abstract No 121571. P. 171-172.	uk_UA
dc.identifier.uri	https://repo.odmu.edu.ua:443/xmlui/handle/123456789/15526
dc.description.abstract	Neuroinflammatory contribution is principal for developing chronic epileptic seizures. The work aimed to investigate chronic seizures and anxious behavior in pentylenetetrazole (PTZ)-kindled rats under combined treatment with the histamine H₃ blocker pitolisant and mTOR blocker rapamycin.	uk_UA
dc.language.iso	en	en
dc.subject	chronic epileptic	en
dc.subject	neuroinflammatory contribution	en
dc.subject	anxious behavior	en
dc.subject	epileptic seizures	en
dc.title	Synergy of antiseizure and anxiolytic action of rapamycin and histamine H₃ inverse agonist pitolisant on the PTZ-kindled seizures	en
dc.type	Article	en